Menadiol Sodium Diphosphate
磷酸二甲萘二酚
Report date: 2023/01/08 19:06:08
NME
Base Information
Drug NameMenadiol Sodium Diphosphate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[12]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1941/07/15
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesWuxi Jialing Medicine Co LtdJiangsu Sihuan Bioengineering Co LtdGuangdong Ai Min Pharmaceutical Co Ltd
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active Indications +[11]
Inactive Indications